Annual accounts receivable:
$1.69M-$12.38M(-87.96%)Summary
- As of today (September 18, 2025), CDTX annual accounts receivable is $1.69 million, with the most recent change of -$12.38 million (-87.96%) on December 31, 2024.
- During the last 3 years, CDTX annual accounts receivable has fallen by -$3.66 million (-68.37%).
- CDTX annual accounts receivable is now -87.96% below its all-time high of $14.07 million, reached on December 31, 2023.
Performance
CDTX Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$1.86M+$165.00K(+9.74%)Summary
- As of today (September 18, 2025), CDTX quarterly accounts receivable is $1.86 million, with the most recent change of +$165.00 thousand (+9.74%) on June 30, 2025.
- Over the past year, CDTX quarterly accounts receivable has dropped by -$490.00 thousand (-20.86%).
- CDTX quarterly accounts receivable is now -92.80% below its all-time high of $25.83 million, reached on March 31, 2023.
Performance
CDTX Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CDTX Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -88.0% | -20.9% |
| 3 y3 years | -68.4% | -61.5% |
| 5 y5 years | - | - |
CDTX Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -88.0% | at low | -92.8% | +9.7% |
| 5 y | 5-year | -88.0% | at low | -92.8% | +9.7% |
| alltime | all time | -88.0% | >+9999.0% | -92.8% | >+9999.0% |
CDTX Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.86M(+9.7%) |
| Mar 2025 | - | $1.69M(0.0%) |
| Dec 2024 | $1.69M(-88.0%) | $1.69M(-0.3%) |
| Sep 2024 | - | $1.70M(-27.7%) |
| Jun 2024 | - | $2.35M(-67.7%) |
| Mar 2024 | - | $7.28M(-48.3%) |
| Dec 2023 | $14.07M(+141.3%) | $14.07M(+393.0%) |
| Sep 2023 | - | $2.85M(-47.9%) |
| Jun 2023 | - | $5.48M(-78.8%) |
| Mar 2023 | - | $25.83M(+342.8%) |
| Dec 2022 | $5.83M | $5.83M(+15.7%) |
| Sep 2022 | - | $5.04M(+4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $4.83M(-45.0%) |
| Mar 2022 | - | $8.78M(+64.0%) |
| Dec 2021 | $5.36M(-52.1%) | $5.36M(+38.3%) |
| Sep 2021 | - | $3.87M(+22.6%) |
| Jun 2021 | - | $3.16M(-71.7%) |
| Dec 2020 | $11.18M(>+9900.0%) | $11.18M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(-100.0%) |
| Jun 2018 | - | $41.00K(-85.8%) |
| Mar 2018 | - | $288.00K(-10.3%) |
| Dec 2017 | $321.00K | $321.00K(0.0%) |
| Sep 2017 | - | $321.00K(+49.3%) |
| Jun 2017 | - | $215.00K |
FAQ
- What is Cidara Therapeutics, Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual accounts receivable year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly accounts receivable year-on-year change?
What is Cidara Therapeutics, Inc. annual accounts receivable?
The current annual accounts receivable of CDTX is $1.69M
What is the all time high annual accounts receivable for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual accounts receivable is $14.07M
What is Cidara Therapeutics, Inc. annual accounts receivable year-on-year change?
Over the past year, CDTX annual accounts receivable has changed by -$12.38M (-87.96%)
What is Cidara Therapeutics, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of CDTX is $1.86M
What is the all time high quarterly accounts receivable for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly accounts receivable is $25.83M
What is Cidara Therapeutics, Inc. quarterly accounts receivable year-on-year change?
Over the past year, CDTX quarterly accounts receivable has changed by -$490.00K (-20.86%)